Clinical Trials Browser

INDUSTRY × Lymphoma, Non-Hodgkin × ocaratuzumab × Clear all

NCT00354926 2016-01-07

Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma

Phase 1 Completed

Lymphoma, Non-Hodgkin